A multinational authority that evaluates and supervises medicinal products recorded more than 1 million injuries and 12,000 deaths of people immunized against the deadly disease.

Netherlands-based EudraVigilance received nearly 1.2 million reports of injuries, and almost 12,200 fatalities, from suspected adverse reactions to multiple Chinese Communist Party (CCP) Virus vaccines.

CCP Virus vaccine adverse reactions dated May 22, 2021. (EudraVigilance Screenshot via TheBL/Health Impact News)

The staggering figures were recorded from patients who were administered the jab manufactured by AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen Pharmaceuticals (Johnson & Johnson).

Health Impact News revealed AstraZeneca’s vaccine allegedly caused the highest number of injuries (655,534,) from which 27 percent suffered general disorders and 21.5 percent experienced nervous system disorders.

BioNTech’s Pfizer was accused of causing the highest number of deaths at 5,961, representing 48.9 percent.

Adverse reactions to Moderna’s experimental mRNA vaccine allegedly caused 3,365 deaths (27.6 percent) and 72,596 injuries (0.6 percent).

Johnson & Johnson’s Janssen vaccine seemed to be the safest with only 369 deaths (0.3 percent) and 15,281 injuries (0.1 percent) reported, according to the publication.

EudraVigilance, which is funded by the European Medicines Agency, shows the highest number of deaths came from victims who showed symptoms of general disorders.

“[BioNTech’s Pfizer caused] 128,031 general disorders and administration site conditions including 1,909 deaths,” Health Impact News reported. “[Moderna’s mRNA caused] 20,774 general disorders and administration site conditions including 1,480 deaths.”

Many patients also suffered from gastrointestinal disorders, nervous system disorders, skin and subcutaneous tissue disorders, and musculoskeletal and connective tissue disorders according to the publication.

CCP Virus vaccine adverse reactions data on May 22, 2021. (EudraVigilance Screenshot via TheBL/Health Impact News)

Sign up to receive our latest news!

By submitting this form, I agree to the terms.